Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX 11:30:14 2024-05-02 am EDT 5-day change 1st Jan Change
27.46 USD +1.01% Intraday chart for Pfizer, Inc. +8.85% -4.50%
Sales 2024 * 60.15B Sales 2025 * 62.48B Capitalization 154B
Net income 2024 * 7.91B Net income 2025 * 9.98B EV / Sales 2024 * 3.45 x
Net Debt 2024 * 53.77B Net Debt 2025 * 42.59B EV / Sales 2025 * 3.14 x
P/E ratio 2024 *
18 x
P/E ratio 2025 *
13.8 x
Employees 88,000
Yield 2024 *
6.23%
Yield 2025 *
6.34%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.34%
1 week+9.68%
Current month+8.14%
1 month+0.56%
3 months+2.88%
6 months-9.16%
Current year-3.77%
More quotes
1 week
25.20
Extreme 25.2
27.72
1 month
25.20
Extreme 25.2
27.75
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-05-02 27.48 +1.12% 20 182 889
24-05-01 27.18 +6.09% 97,521,564
24-04-30 25.62 -0.08% 38,017,739
24-04-29 25.64 +0.94% 41,674,405
24-04-26 25.4 +0.55% 46,526,457

Delayed Quote Nyse, May 02, 2024 at 10:24 am EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.18 USD
Average target price
31.8 USD
Spread / Average Target
+17.00%
Consensus